Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once-weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1-5, 7-10 and SUSTAIN China.
Journal: Diabetes, obesity & metabolism
Published: July 12, 2023
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline.
Journal: BMJ open diabetes research & care
Published: February 16, 2021
Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study.
Journal: BMJ open diabetes research & care
Published: February 16, 2021
Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: October 16, 2019
Efficacy and safety of once-monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo-controlled, 16-week randomized dose-finding study.
Journal: Diabetes, obesity & metabolism
Published: August 22, 2019
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study.
Journal: Diabetes, obesity & metabolism
Published: January 14, 2019
Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide.
Journal: Diabetes care
Published: December 28, 2018
Semaglutide, lipid-lowering drugs, and NAFLD - Author's reply.
Journal: The lancet. Diabetes & endocrinology
Published: March 28, 2017
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial.
Journal: The lancet. Diabetes & endocrinology
Published: November 09, 2016
The dynamic relationship between current and previous severe hypoglycemic events: a lagged dependent variable analysis among patients with type 2 diabetes who have initiated basal insulin.
Journal: Current medical research and opinion
Published: July 22, 2015
New developments in insulin therapy for type 2 diabetes.
Journal: The American journal of medicine
Published: October 06, 2014
Insulin therapy in type 2 diabetes: a reflection on the state of the art today and the potential journeys yet to come.
Journal: The American journal of medicine
Published: October 06, 2014
Last Updated: 09/26/2026